In the present study, we correlated the expression levels of β‐arrestins with sst2, sst5 (at the mRNA and protein levels) or D2 expression and investigated the association of β‐arrestins expression with SRL responsiveness and tumour invasiveness in somatotropinomas. The gene discussed is SSTR5; the disease is growth hormone-producing pituitary gland neoplasm.